Medicare Advantage
The House Ways and Means Committee today approved legislation (H.R. 6142) that would require the Health and Human Services secretary to develop with stakeholders a plan to reduce waste related to single-use drug vials.
The module will allow Medicare plans to request that their payment arrangements receive “an other payer advanced APM determination” as part of the Quality Payment Program mandated by the Medicare Access and CHIP Reauthorization Act.
The Centers for Medicare & Medicaid Services is making Medicare Advantage data available to researchers, beginning with data on services provided to beneficiaries in calendar year 2015.
A new report from the Centers for Medicare & Medicaid Services’ Office of Minority Health looks at racial, ethnic and gender differences on 27 clinical quality and eight patient experience measures for beneficiaries with Medicare Advantage health and drug plans in 2015-2016.
The CMS on April 6 finalized a rule that will update the Medicare Advantage and Part D prescription drug programs for contract year 2019.
The Centers for Medicare & Medicaid Services late this afternoon released a final rule that makes programmatic and operational changes to the Medicare Advantage and prescription drug benefit programs for contract year 2019.
AHA's comment on CMS's 2019 Advance Notice and draft Call Letter for 2019.
AHA Special Bulletin: White House Releases FY 2019 Budget Request with Medicare, Medicaid Reductions
President Trump today submitted to Congress his budget request for fiscal year (FY) 2019.
The AHA generally supports the Centers for Medicare & Medicaid Services’ proposals to increase flexibility in plan design, cost sharing and enrollment for the Medicare Advantage and prescription drug programs in 2019, but recommends caution to ensure that the added flexibility provides value…